PT3003289T - Administração de antibacterianos híbridos de oxazolidinona-quinolona - Google Patents

Administração de antibacterianos híbridos de oxazolidinona-quinolona

Info

Publication number
PT3003289T
PT3003289T PT14723716T PT14723716T PT3003289T PT 3003289 T PT3003289 T PT 3003289T PT 14723716 T PT14723716 T PT 14723716T PT 14723716 T PT14723716 T PT 14723716T PT 3003289 T PT3003289 T PT 3003289T
Authority
PT
Portugal
Prior art keywords
oxazolidinone
administration
quinolone hybrid
antibacterials
hybrid antibacterials
Prior art date
Application number
PT14723716T
Other languages
English (en)
Inventor
Kapsner Thomas
Dalhoff Axel
Gramatte Thomas
Original Assignee
Morphochem Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphochem Gmbh filed Critical Morphochem Gmbh
Publication of PT3003289T publication Critical patent/PT3003289T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dermatology (AREA)
PT14723716T 2013-05-28 2014-05-09 Administração de antibacterianos híbridos de oxazolidinona-quinolona PT3003289T (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13002762 2013-05-28
EP13005745 2013-12-10
EP13005748 2013-12-10

Publications (1)

Publication Number Publication Date
PT3003289T true PT3003289T (pt) 2019-06-04

Family

ID=50721743

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14723716T PT3003289T (pt) 2013-05-28 2014-05-09 Administração de antibacterianos híbridos de oxazolidinona-quinolona

Country Status (23)

Country Link
US (2) US10723746B2 (pt)
EP (2) EP3517106A1 (pt)
JP (1) JP6407982B2 (pt)
KR (1) KR102214843B1 (pt)
CN (2) CN105338972A (pt)
AU (1) AU2014273510B2 (pt)
BR (1) BR112015029488A8 (pt)
CA (1) CA2912590C (pt)
CY (1) CY1121996T1 (pt)
DK (1) DK3003289T3 (pt)
ES (1) ES2726828T3 (pt)
HR (1) HRP20190977T1 (pt)
HU (1) HUE043786T2 (pt)
IL (1) IL242771B (pt)
LT (1) LT3003289T (pt)
MX (1) MX371037B (pt)
NZ (1) NZ713945A (pt)
PL (1) PL3003289T3 (pt)
PT (1) PT3003289T (pt)
RS (1) RS58915B1 (pt)
RU (1) RU2702364C2 (pt)
SI (1) SI3003289T1 (pt)
WO (1) WO2014191075A1 (pt)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689769B2 (en) 2000-12-21 2004-02-10 Pharmacia & Upjohn Company Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
ES2186550B2 (es) 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
WO2003031441A1 (en) 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
US20070155714A1 (en) 2003-04-30 2007-07-05 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
ZA200509147B (en) * 2003-04-30 2007-03-28 Morphochem Ag Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
CN1898238A (zh) * 2003-12-18 2007-01-17 莫弗凯姆联合化学股份公司 噁唑烷酮-喹诺酮杂化物抗生素
US8158797B2 (en) * 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
AR054608A1 (es) 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
US20090264342A1 (en) * 2006-02-13 2009-10-22 Trustees Of Boston University Compositions and methods for antibiotic potentiation and drug discovery
JP4484965B2 (ja) 2006-11-10 2010-06-16 アクテリオン ファーマシューティカルズ リミテッド 5−ヒドロキシメチル−オキサゾリジン−2−オン誘導体
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
NZ589734A (en) * 2008-05-09 2012-11-30 Actelion Pharmaceuticals Ltd 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases

Also Published As

Publication number Publication date
JP6407982B2 (ja) 2018-10-17
AU2014273510B2 (en) 2019-10-10
PL3003289T3 (pl) 2019-09-30
EP3003289B1 (en) 2019-02-20
KR102214843B1 (ko) 2021-02-15
US10723746B2 (en) 2020-07-28
RU2015155645A (ru) 2017-07-04
HRP20190977T1 (hr) 2019-08-23
RU2702364C2 (ru) 2019-10-08
CN105338972A (zh) 2016-02-17
ES2726828T3 (es) 2019-10-09
IL242771B (en) 2020-08-31
HUE043786T2 (hu) 2019-09-30
JP2016523853A (ja) 2016-08-12
US20200392168A1 (en) 2020-12-17
MX2015016320A (es) 2016-06-02
BR112015029488A2 (pt) 2017-07-25
RS58915B1 (sr) 2019-08-30
CN112089714A (zh) 2020-12-18
DK3003289T3 (da) 2019-05-20
NZ713945A (en) 2020-05-29
CA2912590C (en) 2022-11-29
LT3003289T (lt) 2019-06-25
US20160130288A1 (en) 2016-05-12
EP3003289A1 (en) 2016-04-13
MX371037B (es) 2020-01-14
CY1121996T1 (el) 2020-10-14
CA2912590A1 (en) 2014-12-04
EP3517106A1 (en) 2019-07-31
WO2014191075A1 (en) 2014-12-04
US11261205B2 (en) 2022-03-01
HK1223306A1 (en) 2017-07-28
BR112015029488A8 (pt) 2019-12-17
KR20160013193A (ko) 2016-02-03
SI3003289T1 (sl) 2019-08-30
AU2014273510A1 (en) 2015-12-17

Similar Documents

Publication Publication Date Title
IL287516A (en) Medicinal uses of empagliflozin
IL241101A0 (en) Medicinal uses of empagliflozin
EP2955796A4 (en) VEHICLE SIDE CONNECTOR
AU356418S (en) Charger
IL241102A0 (en) Medicinal uses of empagliflozin
SI2981271T1 (sl) Terapevtske uporabe empagliflozina
IL245524A0 (en) New methods for the production of active tert
GB201308440D0 (en) Therapeutic
GB201318668D0 (en) Sonosensitive therapeutic
LT3003289T (lt) Oksazolidinono-chinolono hibrido kaip antibakterinio preparato įvedimas
AU5380P (en) Sunparacoho Mandevilla hybrid
AU5577P (en) Sunpararopi Mandevilla hybrid
AU5265P (en) ABCRD01 Helleborus hybrid
AU5264P (en) ABCRD02 Helleborus hybrid
AU5352P (en) Magic Marmalade Ozothamnus hybrid
AU5378P (en) Suncallemon Calibrachoa hybrid
AU5377P (en) Suncalred Calibrachoa hybrid
AU4978P (en) USCAL91001 Calibrachoa hybrid
AU4979P (en) USCAL5302M Calibrachoa hybrid
AU5429P (en) Q253 Saccharum hybrid
AU5001P (en) Q254 Saccharum hybrid
AU5000P (en) Q252 Saccharum hybrid
AU5002P (en) Q256 Saccharum hybrid
AU5254P (en) MicJur02 Michelia hybrid
AU2013232V (en) Bonmadrosepi Argyranthemum hybrid